[185 Pages Report] The Next Generation Sequencing Market size was estimated at USD 17.73 billion in 2023 and expected to reach USD 21.38 billion in 2024, at a CAGR 23.61% to reach USD 78.21 billion by 2030.
Next-generation sequencing (NGS) is the parallel sequencing technology that delivers ultra-high throughput, scalability, and speed. The technology is operated to determine the order of nucleotides in whole genomes or targeted regions of DNA or RNA. This high-throughput technique defines a part of the nucleotide sequence of an individual's genome that utilizes DNA sequencing technologies capable of processing multiple DNA sequences in parallel. Governments worldwide strive to keep healthcare expenditure affordable while providing equal access to high-quality care, leading to increased awareness and adoption of clinical diagnostics among patients, such as NGS technology. Growing technological developments in NGS instruments and technologies and rising adoption by the agriculture sector are driving the market growth. However, privacy concerns regarding next-generation sequencing data protection and a need for computation resources for next-generation sequencing hamper market growth. Continuous technological development of NGS products and government support and initiatives are expected to create significant market opportunities in the future.
The Americas is a significant market in next-generation sequencing owing to the increasing number of research projects, rising demand for new NGS platforms, and growing use of NGS consumables projected market development. With high R&D investment and the availability of a technologically developed healthcare research framework, the development of whole genome sequencing (WGS) in the region is a critical factor for the market's growth. In Europe, increasing usage of NGS in the centers performing ground-level research and rising development and advancement in research in sequencing have created a significant expansion in the region. In the Asia-Pacific, the market is estimated to grow rapidly over the forecast period owing to the presence of substantial developments by China and Japan for technological integration of NGS methodologies and the development of healthcare, R&D, and clinical development frameworks of emerging economies such as India and Australia have poised the Asia-Pacific NGS market to witness lucrative opportunities of expansion.
The market dynamics represent an ever-changing landscape of the Next Generation Sequencing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Next Generation Sequencing Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Next Generation Sequencing Market.
The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Next Generation Sequencing Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.
The value chain of the Next Generation Sequencing Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.
The pricing analysis comprehensively evaluates how a product or service is priced within the Next Generation Sequencing Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Next Generation Sequencing Market.
The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Next Generation Sequencing Market.
The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Next Generation Sequencing Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.
The trade analysis of the Next Generation Sequencing Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.
The regulatory framework analysis for the Next Generation Sequencing Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Next Generation Sequencing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Next Generation Sequencing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
QIAGEN completes acquisition of Verogen, strengthening leadership in Human ID / Forensics with NGS technologies.
QIAGEN, a global leading provider of Sample to Insight molecular diagnostic and research solutions, has completed its acquisition of Verogen, a leader in human identification and forensic genomics with Next Generation Sequencing (NGS) technologies. With this strategic move, QIAGEN aims to strengthen its leadership position in human identification and forensic science by expanding its portfolio of NGS-based solutions. The company's commitment to investing in the development of NGS verticals reinforces its dedication to providing high-quality, cutting-edge solutions to the forensic community. The acquisition of Verogen is a critical milestone in QIAGEN's quest to revolutionize human diagnostics and research. The synergies generated by combining the two companies' strengths in biotechnology and data analysis are sure to have a profound impact on the forensic and human identification industry. [Published On: 2023-01-09]
QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases.
QIAGEN and Helix have announced an exclusive partnership to advance the production of Next Generation Sequencing (NGS) Companion Diagnostics for hereditary diseases. This collaboration merges Helix’s scalable NGS platform with QIAGEN’s proprietary bioinformatics solutions to create a comprehensive diagnostics offering for precision medicine. With hereditary diseases affecting millions of people worldwide, this partnership holds great promise in expanding the reach and accessibility of personalized healthcare. Both QIAGEN and Helix bring their expertise and resources to this collaboration, highlighting a commitment to advancing the field of genomics through innovative partnerships. [Published On: 2023-01-05]
Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research.
Agilent, a leading life sciences company, has recently announced their acquisition of Avida Biomed, a developer of high-performance NGS target enrichment workflows for cancer research. This acquisition will allow Agilent to expand their offerings in the rapidly growing market of Next Generation Sequencing (NGS). NGS technology has revolutionized the field of genomics, allowing for faster and more accurate analysis of DNA and RNA sequences, which has been invaluable in cancer research. With this acquisition, Agilent is reaffirming their commitment to providing researchers with powerful tools to accelerate scientific discovery and improve patient outcomes. [Published On: 2023-01-04]
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Next Generation Sequencing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
The report delves into recent significant developments in the Next Generation Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., ATDBio Ltd., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., BIO3 SCIENTIFIC SDN BHD, bioMerieux S.A., BioVendor–Laboratorní medicína a.s, Cambridge Bioscience Limited, CD Genomics, CeGaT GmbH, Charles River Laboratories, Inc., DNAnexus, Inc., DNASTAR, Inc., ELEMENT BIOSCIENCES, Enzo Life Sciences, Inc., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fraunhofer-Gesellschaft, GENEWIZ, Genomatix, GenPath, GenScript Biotech Corporation, GRAIL, LLC, Hamilton Company, Illumina, Inc., Integrated DNA Technologies, Inc., Invivoscribe, Inc., iRepertoire, Inc., LabMal, Macrogen, Inc., Medigene Sdn Bhd., Merck KGaA, NanoString Technologies, Inc., Neoscience, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PathoQuest, PCR Biosystems Ltd., Perkin Elmer, Inc., Promega Corporation, PT Pandu Biosains, Qiagen N.V., Resolution Bioscience, Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..
This research report categorizes the Next Generation Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Technology
- Targeted Sequencing & Re-Sequencing
- Whole Exome Sequencing
- Whole Genome Sequencing
- Product Type
- Consumables
- Platforms
- Services
- Application
- Agriculture
- Animal science & Veterinary Research
- Diagnostics
- Drug Discovery
- End User
- Academic & Research Institutes
- Clinical Laboratories
- Contract Research Organization
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Next Generation Sequencing Market, by Technology
- Next Generation Sequencing Market, by Product Type
- Next Generation Sequencing Market, by Application
- Next Generation Sequencing Market, by End User
- Americas Next Generation Sequencing Market
- Asia-Pacific Next Generation Sequencing Market
- Europe, Middle East & Africa Next Generation Sequencing Market
- Competitive Landscape
- Competitive Portfolio
- List of Figures [Total: 24]
- List of Tables [Total: 382]
- List of Companies Mentioned [Total: 48]
Analyzing Plant Genomes:
With NGS technology, the sequencing of an entire plant genome can be completed in a few weeks, which previously took years. Sequencing enables us to identify the location of specific genes and mutations within the DNA that gives rise to particular plant traits. For instance, sequencing can predict disease resistance by examining alleles that confer resistance. With this information, agricultural scientists can find ways to develop more disease-resistant crops, which could translate into better yields and a more uniform production system. The ability to sequence plants quickly and accurately using NGS technology is an incredible achievement for the plant breeding industry.
Identifying Genetic Markers:
One of the most significant benefits of NGS technology in agriculture is identifying genetic markers specific to plant characteristics. We can create custom plant varieties that meet specific needs by identifying genetic markers associated with traits like sugar content, drought tolerance, and disease resistance. By using these genetic markers, breeders can breed plants with the required attributes and avoid wasting time and resources on plants that do not meet the requirements. The use of NGS technology in agriculture is, therefore, likely to reduce the development time of new crop varieties and also contribute to the production of more resilient crops.
Tracking Disease and Pests:
NGS technology can also be used to track pathogen transmission and identify disease outbreaks in plants. Pathogens can move from one region to another via wind, water, and other environmental factors. By identifying the location of pathogen DNA, NGS technology can help determine the origin of an outbreak, giving farmers time to take appropriate preventative measures. In addition, NGS technology can also help identify isolated cases offering new opportunities to fight outbreaks and protect our crops.
Nutrigenomics:
Another application of NGS technology in agriculture is the analysis of gene expression in crops. Nutrigenomics studies identify the impact of nutrients or bioactive compounds in the diet on the expression of an individual's genome. Genomics is considered a unique approach to understanding the interactions between dietary compounds and human health. A similar approach in agronomy would help identify how we can optimize the nutrient content of our crops to support population health.
Precision Agriculture:
NGS technology in agriculture can also support precision agriculture. The detailed plant genomic data enables farmers to optimize inputs while minimizing unintended environmental effects. It brings together mapping, sensors, IoT, drones, and the use of genomic data to increase our ability to understand how plants interact with the environment and how precision agriculture can be employed.
The use of NGS technology in agriculture has revolutionized the industry by enabling large-scale genomic analysis, the identification of specific genetic markers, and disease tracking. The benefits of NGS technology are vast for the agriculture industry, including faster crop development, disease tracking, customized breeding programs, improved yield, and better environmental management. With the technology continuing to advance, we can expect to see more innovative applications for NGS in the future and an even bigger impact on agriculture.
- How big is the Next Generation Sequencing Market?
- What is the Next Generation Sequencing Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?